
Fennec Pharmaceuticals Hits Day High with Strong 7.98% Intraday Surge
2025-10-01 16:51:13Fennec Pharmaceuticals, Inc. has seen a notable increase in stock performance, achieving significant gains over various time frames. While it has outperformed the S&P/TSX 60 index, the company faces challenges such as a negative book value and declining net sales, raising concerns about its long-term sustainability.
Read MoreNo announcement available
Corporate Actions
No corporate action available






